Fluparoxan: A Comprehensive Review of its Discovery, Adrenergic and CNS Activity and Treatment of Cognitive Dysfunction in Central Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|17|7|572-582

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.17, Iss.7, 2017-04, pp. : 572-582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting CNS Transporters for Treatment of Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 20, Iss. 10, 2014-03 ,pp. : 1523-1533

Bentham Science Publishers

Access to resources Recommend Favorite

Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 31, 2011-10 ,pp. : 3356-3373

Bentham Science Publishers

Access to resources Recommend Favorite

Histamine H3 Antagonists for Treatment of Cognitive Deficits in CNS Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 153-169

Bentham Science Publishers

Access to resources Recommend Favorite

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

By Orlacchio Antonio   Bernardi Giorgio   Orlacchio Aldo   Martino Sabata  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 10, 2008-10 ,pp. : 1161-1174

Informa Healthcare

Access to resources Recommend Favorite

Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 7, 2011-01 ,pp. : 849-862

Bentham Science Publishers

Access to resources Recommend Favorite